Russian strains of group B streptococci are different in the content and organization of the PAI-A and PAI-A1 pathogenicity islands
- Authors: Kuleshevich E.V.1, Ilyasov Y.Y.1, Linnik D.S.1, Malchenkova A.A.1, Arzhanova O.N.2, Briko N.I.3, Glushkova E.V.3, Priputnevich T.V.4, Suvorov A.N.1,5
-
Affiliations:
- Institute of Experimental Medicine
- Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott, Saint Petersburg State University
- I.M. Sechenov First Moscow State Medical University
- National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
- Saint Petersburg State University
- Issue: Vol 70, No 4 (2021)
- Pages: 65-72
- Section: Original study articles
- URL: https://journals.rcsi.science/jowd/article/view/61875
- DOI: https://doi.org/10.17816/JOWD61875
- ID: 61875
Cite item
Abstract
Group B streptococci, or Streptococcus agalactiae, are the major cause of severe diseases in newborns and adults. The PAI-A and PAI-A1 pathogenicity islands containing the sspB1 and sspB1a genes, respectively, were found among group B streptococci mobile genetic elements. The presence of sspB genes correlates with urogenital tract infections. The aim of this study was to determine the frequency of group B streptococci strains with the PAI-A and PAI-A1 pathogenicity islands, circulating in Moscow, in comparison with strains from St. Petersburg. The sspB1 gene, and hence the PAI-A pathogenicity island, was not found in the genomes of strains from Moscow. The frequency of the sspB1a gene and the PAI-A1 pathogenicity island in the genomes of clinical strains was three times higher than in the genomes of colonizing strains. Thus, it can be assumed that the genes of the sspB family are more specific of group B streptococci colonizing pregnant women and newborns.
Full Text
##article.viewOnOriginalSite##About the authors
Evgenia V. Kuleshevich
Institute of Experimental Medicine
Email: k-zh-v@mail.ru
ORCID iD: 0000-0002-3180-6491
Cand. Sci. (Biol.)
Russian Federation, Saint PetersburgYury Y. Ilyasov
Institute of Experimental Medicine
Email: kolpino@hotmail.com
SPIN-code: 2204-1677
Russian Federation, Saint Petersburg
Dmitry S. Linnik
Institute of Experimental Medicine
Email: linnikdm@yandex.ru
ORCID iD: 0000-0002-8046-9743
Russian Federation, Saint Petersburg
Anastasia A. Malchenkova
Institute of Experimental Medicine
Email: nastya.malchenkova@yandex.ru
ORCID iD: 0000-0003-2201-0472
SPIN-code: 8957-5056
Russian Federation, Saint Petersburg
Olga N. Arzhanova
Research Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott,Saint Petersburg State University
Email: arjanova_olga@mail.ru
ORCID iD: 0000-0003-3059-9811
MD, Dr. Sci. (Med.), Professor, Honored Doctor of the Russian Federation, Leading Researcher. The Department of Obstetrics and Perinatology; Professor. The Department of Obstetrics, Gynecology, and Reproductive Sciences, Medical Faculty
Russian Federation, 3 Mendeleevskaya Line, Saint Petersburg, 199034; 7-9 Universitetskaya emb., St. Petersburg, 199034Nikolay I. Briko
I.M. Sechenov First Moscow State Medical University
Email: nbrico@mail.ru
ORCID iD: 0000-0002-6446-2744
SPIN-code: 2992-6915
MD, Dr. Sci. (Med.), Professor, Honored Scientist of the Russian Federation, Academician of the Russian Academy of Sciences
Russian Federation, 8-2 Trubetskaya str., Moscow, 119991Ekaterina V. Glushkova
I.M. Sechenov First Moscow State Medical University
Email: ekaterina-1801@mail.ru
ORCID iD: 0000-0001-6997-7598
SPIN-code: 2336-3176
MD, Cand. Sci. (Med.)
Russian Federation, 8-2 Trubetskaya str., Moscow, 119991Tatyana V. Priputnevich
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Email: priput1@gmail.com
ORCID iD: 0000-0002-4126-9730
SPIN-code: 8383-7023
MD, Dr. Sci. (Med.)
Russian Federation, 4 Street Akademika Oparina, Moscow, 117997Alexander N. Suvorov
Institute of Experimental Medicine; Saint Petersburg State University
Author for correspondence.
Email: alexander_suvorov1@hotmail.com
ORCID iD: 0000-0003-2312-5589
SPIN-code: 8062-5281
MD, Dr. Sci. (Med.), Professor, Corresponding Member of the Russian Academy of Sciences
Russian Federation, Saint Petersburg; Saint PetersburgReferences
- Totolyan AA, Suvorov AN, Dmitriev AV. Streptokokki gruppy V v patologii cheloveka. Saint Petersburg: Chelovek; 2009. (In Russ.)
- Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379(9815):547–556. doi: 10.1016/S0140-6736(11)61651-6
- Vasilyeva VA, Shipitsyna EV, Shalepo KV, et al. Molecular epidemiology of infections caused by group B streptococcus in pregnant women and newborns, and development of preventive vaccines. Journal of Obstetrics and Women’s Diseases. 2018;67(5):62–73. (In Russ.). doi: 10.17816/JOWD67562-73
- Shabayek S, Spellerberg B. Group B streptococcal colonization, molecular characteristics, and epidemiology. Front Microbiol. 2018;9:437. doi: 10.3389/fmicb.2018.00437
- Madrid L, Seale AC, Kohli-Lynch M, et al. Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(Suppl 2):S160–S172. doi: 10.1093/cid/cix656
- Song JY, Lim JH, Lim S, et al. Progress toward a group B streptococcal vaccine. Hum Vaccin Immunother. 2018;14(11):2669–2681. doi: 10.1080/21645515.2018.1493326
- Lindahl G, Stålhammar-Carlemalm M, Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev. 2005;18(1):102–127. doi: 10.1128/CMR.18.1.102-127.2005
- Suvorov AN, Grabovskaya KB, Leontyeva GF, et al. Recombinant fragments of conservative proteins of group B Streptococci as a basis of specific vaccine. Zhurnal mikrobiologii, èpidemiologii i immunobiologiiZhurnal mikrobiologii, èpidemiologii i immunobiologii. 2010;2:44–50. (In Russ.)
- Chmouryguina I, Suvorov A, Ferrieri P, Cleary PP. Conservation of the C5a peptidase genes in group A and B streptococci. Infect Immun. 1996;64(7):2387–2390. doi: 10.1128/IAI.64.7.2387-2390.1996
- Cleary PP, Handley J, Suvorov AN, et al. Similarity between the group B and A streptococcal C5a peptidase genes. Infect Immun. 1992;60(10):4239–4244. doi: 10.1128/IAI.60.10.4239-4244.1992
- Rajagopal L. Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol. 2009;4(2):201–221. doi: 10.2217/17460913.4.2.201
- Suvorov A, Grabovskaja K, Savicheva A, et al. Determination of group B streptococcal genes encoding putative adherence factors in GBS clinical strains. Streptococci – New Insights Into an Old Enemy. 2006;1289:227–230. doi: 10.1016/j.ics.2005.11.026
- Oganyan KA, Suvorov AN, Zaciorskaya SL, et al. The course and outcomes of pregnancy in women with urogenital tract colonization witgroup B streptococcus inclusive genes of sspB family. Journal of Obstetrics and Women’s Diseases. 2006;55(2):47–52. (In Russ.)
- Kramskaya TA, Leontyeva GF, Grabovskaya KB, et al. The analysis of protective activity of polyvalent group В streptococcal recombinant vaccine based on conserved surface proteins. Medicinskij alfavit. 2015;1(6):30–33. (In Russ.)
- Gupalova T, Leontieva G, Kramskaya T, et al. Development of experimental GBS vaccine for mucosal immunization. PLoS One. 2018;13(6):e0198577. doi: 10.1371/journal.pone.0198577
- Filimonova VYu, Dukhovlinov IV, Kramskaya TA, et al. Chimeric proteins based on the immunogenic epitopes of streptococcus surface pathogenicity factors as vaccines for group B streptococcal infections. Medicinskij akademicheskij zhurnal. 2016;16(3):82–89. (In Russ.). doi: 10.17816/MAJ16382-89
- Glaser P, Rusniok C, Buchrieser C, et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Molecular Microbiology. 2002;45(6):1499–513. doi: 10.1046/j.1365-2958.2002.03126.x
- Tettelin H, Masignani V, Cieslewicz MJ, et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci USA. 2002;99(19):12391–12396. doi: 10.1073/pnas.182380799
- Brochet M, Couve E, Glaser P, et al. Integrative conjugative elements and related elements are major contributors to the genome diversity of Streptococcus agalactiae. J Bacteriol. 2008;190(20):6913–6917. doi: 10.1128/JB.00824-08
- Herbert MA, Beveridge CJE, McCormick D, et al. Genetic islands of Streptococcus agalactiae strains NEM316 and 2603VR and their presence in other Group B Streptococcal strains. BMC Microbiology. 2005;5(31):1–13. doi: 10.1186/1471-2180-5-31
- Kuleshevich E, Ferretti J, Santos Sanches I, et al. Clinical strains of Streptococcus agalactiae carry two different variants of pathogenicity island XII. Folia Microbiol (Praha). 2017;62(5):393–399. doi: 10.1007/s12223-017-0509-8
- Poyart C, Tazi A, Réglier-Poupet H, et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol. 2007;45(6):1985–1988. doi: 10.1128/JCM.00159-07
- Kuleshevich EV, Savicheva AM, Arzhanova ON, et al. Distribution and genetic organization of pathogenicity island XII among the clinical strains of GBS. Molecular genetics, microbiology and virology. 2013;28(1):15–19. doi: 10.3103/S0891416813010023
Supplementary files
